Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

By Alexander E. Gorbalenya, S. Baker, Ralph S. Baric, R. D. de Groot, Christian Drosten, Anastasia A. Gulyaeva, B. Haagmans, C. Lauber, A. M. Leontovich, B. Neuman and 7 more. bioRxiv, 2020

1,586 citations recorded by the source corpus.

The present outbreak of lower respiratory tract infections, including respiratory distress syndrome, is the third spillover, in only two decades, of an animal coronavirus to humans resulting in a major epidemic. Here, the Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses, which is responsible for developing the official classification of viruses and taxa naming (taxonomy) of the Coronaviridae family, assessed the novelty of the human pathogen tentatively named 2019-nCoV. Based on phylogeny, taxonomy and established practice, the CSG formally recognizes this virus as a sister to severe acute respiratory syndrome coronaviruses (SARS-CoVs) of the species Severe acute respiratory syndrome-related coronavirus and designates it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To facilitate communication, the CSG further proposes to use the following naming convention for individual isolates: SARS-CoV-2/Isolate/Host/Date/Location. The spectrum of clinical manifestations associated with SARS-CoV-2 infections in humans remains to be determined. The independent zoonotic transmission of SARS-CoV and SARS-CoV-2 highlights the need for studying the entire (virus) species to complement research focused on individual pathogenic viruses of immediate significance. This research will improve our understanding of virus-host interactions in an ever-changing environment and enhance our preparedness for future outbreaks.

Subfields: Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/632634d6eb11586bf1269001f359a14cbbe8b43e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Philippe Lemey
2. Maciej F. Boni
3. Andrew Rambaut

Citations in the corpus

• Effects of temperature variation and humidity on the death of COVID-19 in Wuhan, China (2020, neutral): “In December 2019, a novel coronavirus disease (COVID-19) epidemic was reported in Wuhan, China, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Gorbalenya, 2020; Wu et al., 2020).”
• Coronavirus Disease 2019 (COVID-19): A Perspective from China (2020, background): “In Pre ss February 11, 2020, the Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses finally designated it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on phylogeny, taxonomy and established practice (21).”
• Coronavirus disease 2019 (COVID-19): A literature review (2020, neutral): “This pathogen was later renamed as evere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by he Coronavirus Study Group [3] and the disease was named coroavirus disease 2019 (COVID-19) by the WHO.”
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges (2020, neutral): “Regarding the virus itself, the International ommittee on Taxonomy of Viruses has renamed the previusly provisionally named 2019-nCoV as severe acute respiratory yndrome coronavirus-2 (SARS-CoV-2) [3] .”
• Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know (2020, background): “416 American Journal of Obstetrics & Gynecology On Feb. 11, the new coronavirus disease (previously referred to as 2019 novel coronavirus (2019-nCoV)) received an official name from the World Health Organization (WHO), Coronavirus Disease 19 (COVID-19) (Figure 2).6 The International Committee on Tax”
• Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures (2020, background): “A recent large diagnostic study(72) showed 316 patients were confirmed infected with multiple respiratory pathogens including common human coronavirus (5 cases), influenza A virus (2), rhinovirus (12), and influenza A H3N2 (12), respiratory syncytial virus (7), influenza B virus (6), metapneumovirus”
• Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial (2020, background): “Sequencing analysis of throat swabs samples and electron microscope observations indicated a novel coronavirus, which was named SARS-CoV-2 (formerly known as 2019-nCoV) [2].”
• COVID-19: what has been learned and to be learned about the novel coronavirus disease (2020, background): “Patients with fever and/or respiratory symptoms and acute fever, even without pulmonary imaging abnormalities, should be screened for the virus for early diagnosis [39-41].”
• Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets (2020, neutral): “This has been exemplified by the novel coronavirus, known as SARS-CoV-2, which was first identified as the cause of an outbreak of pneumonia in Wuhan, China, in December 2019, and rapidly spread around the world 1–3 .”